New study quantifies the incidence of neuropsychiatric events in children with flu

FHS
July 24, 2023
7:23 pm

While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to treat flu in children has sparked concern among parents and medical professionals alike.

Upadacitinib Shows Long-Term Benefits in Teens With Atopic Dermatitis

Treatment with the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) showed a favorable long-term benefit-risk profile through 76 weeks in adolescents with moderate to severe atopic

October 26, 2024

A century after the last major TB vaccine breakthrough, Gates and Wellcome commit $550M for PhIII test of GSK shot

Two nonprofit organizations are teaming up for a giant study of an experimental vaccine designed to protect against the world’s deadliest infectious disease. The Bill

June 29, 2023

MRI-guided SBRT reduces side effects in prostate cancer treatment

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.